Seelos Therapeutics Inc.
NASDAQ:SEEL
Featured Articles and Interviews
More Featured Articles and Inverviews
Press Releases
More Press Releases
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System ("CNS") disorders and other rare disorders.
Interactive Chart
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â